Interestingly, SCD appears to be a regulatory nexus of de novo FAS in AML cells, because oleate decreases FAS both in resistant and sensitive cells, rescuing SSI-4-mediated toxicity both by replenishing the MUFA pool, but also preventing SFA production. Here, SCD is linked to acute myeloid leukemia.